37,548 results on '"THALASSEMIA"'
Search Results
2. A Real-World Study of β-Thalassemia Major Treatment With Luspatercept in Taiwan
3. ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
4. Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
5. A Research Study Looking at a Single Dose of Etavopivat in Healthy Chinese Participants
6. Long-term Follow-up of Subjects With Transfusion-Dependent β-Thalassemia (TDT) Treated With Ex Vivo Gene Therapy
7. Effects of Hydroxyurea and Metformin in Transfusion Dependent Beta-Thalassemia
8. A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia (FLORAL)
9. Investigating the Mechanistic Effects of Mitapivat in Subjects With Sickle Cell Disease
10. A Study of Etavopivat in Patients With Thalassemia or Sickle Cell Disease (GLADIOLUS)
11. ß-Thalassemia Major with Autologous CD34+ Hematopoietic Progenitor Cells Transduced with TNS9.3.55 a Lentiviral Vector Encoding the Normal Human ß-Globin Gene
12. A Study to Determine the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AG-348 in Adult Participants With Non-transfusion-dependent Thalassemia
13. A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT) (ENERGIZE-T)
14. CINC424A2X01B Rollover Protocol
15. A Study to Evaluate Luspatercept (ACE-536) in Chinese Participants Who Require Regular Red Blood Cell Transfusions Due to Beta (β)-Thalassemia.
16. Psychiatric Problems in Thalassemic Children
17. A Study to Determine the Efficacy and Safety of Luspatercept in Adult and Adolescent Participants With Alpha (α)-Thalassemia
18. Genetic Profile of Alpha Thalassemia Children at Sohag University Hospital .
19. Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling
20. Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-Thalassemia
21. Screening for Alpha Thalassemia in Healthy Volunteers
22. A Long-Term Follow-Up Study of Participants With Sickle Cell Disease or Transfusion Dependent β-Thalassemia Who Received EDIT-301
23. A Long-term Follow-up Study in Participants Who Received CTX001
24. A Study of Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel
25. Epidemiology of Silent and Overt Strokes in Sickle Cell Disease (ESCD)
26. A Post-Marketing Surveillance Study to Assess Safety of Luspatercept in Korean Patients With Myelodysplastic Syndrome or β-thalassemia
27. A Study to Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of Transfusion-dependent (TD) Anemia Associated With Myelodysplastic Syndromes (MDS) & Beta-thalassemia (β-Thal) in India
28. Adherence of Beta Thalssemia Patients to Oral Chelation Therapy
29. Autologous Testicular Tissue Transplantation
30. FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
31. Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major: A Multicenter, Prospective Clinical Study
32. Evaluation the Safety and Efficacy of KL003 Cell Injection in the Treatment of Transfusion-dependent β-thalassemia.
33. T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias
34. ALS20-101 Lentiviral Gene Therapy for Beta Thalassemia
35. Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
36. Plasticizer Exposure and Its Consequences on Health (PEACH)
37. Pharmacotherapy Prescribing Pattern and the Adherence Level to Iron Chelation Therapy in Thalassemia
38. An Open-label Study of a Gene Therapy Product (Vebeglogene Autotemcel) in Transfusion Dependent Beta-Thalassemia
39. Vitamin E Supplementation for Children With Transfusion Dependent Beta Thalassemia on Different Iron Chelation Regimen
40. Unraveling the Impact of Thalidomide at Diverse Doses in Transfusion Dependent Beta Thalassemia (BTM)
41. Study to Evaluate Additional Risk Minimisation Measures (aRMMs) for REBLOZYL Among Healthcare Professionals (HCPs)
42. A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Non-Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-NTDT) (ENERGIZE)
43. Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant Diseases
44. A Research Study of the Effect of Food on Etavopivat in Healthy Participants
45. A Safety and Efficacy Study Evaluating CS-101 in Subjects With β-Thalassemia Major
46. Long Term Beta Thalassemia Treatment: Findings From The Extension Period (Thalidomide)
47. A Study of Safety and Efficiency of AND017 in Patients With β-thalassemia
48. A Long-term Follow-up Study in Participants Who Received CS-101
49. A Study to Test the Safety, Tolerability, and Efficacy of an Antibody, REGN7999, Injected Under the Skin for the Treatment of Iron Overload in Adult Participants With Non-Transfusion Dependent β-thalassemia, Using MRI Scans to Measure Iron Levels in the Body (FERVENT-1)
50. A Phase 1 Study of Gene-modified Autologous Hematopoietic Stem Cell (BD211) Treating β-thalassemia Major
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.